Skip to Content

435 (Mesalamine Delayed-Release 800 mg)

Pill with imprint 435 is Brown, Capsule-shape and has been identified as Mesalamine Delayed-Release 800 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis, maintenance; ulcerative colitis; ulcerative proctitis and belongs to the drug class 5-aminosalicylates. Excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 800 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 435

Mesalamine Delayed-Release

Imprint
435
Strength
800 mg
Color
Brown
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
5-aminosalicylates
Pregnancy Category
B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
70771-1110
Inactive Ingredients
acetyltributyl citrate, silicon dioxide, ferric oxide red, magnesium stearate, methacrylic acid, microcrystalline cellulose, povidone, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide, ferrosoferric oxide, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "435"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.